zaleplon has been researched along with eszopiclone in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 13 (61.90) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Choi, Y; Raymer, BK | 1 |
| Kripke, DF | 2 |
| McKenzie, WS; Rosenberg, M | 1 |
| Luks, AM | 1 |
| Friedman, GD | 1 |
| Dawson, A; Joya, FL; Kline, LE; Kripke, DF; Loving, RT | 1 |
| Hang, E; Miller, AR; Nordahl, TE; Schaffer, CB; Schaffer, LC | 1 |
| Hardy, BT; Hovda, LR; Lancaster, AR; Lee, JA; Martin, EP; Miyahara, LX; Whelan, MF | 1 |
| Greenblatt, DJ; Zammit, GK | 1 |
| Huedo-Medina, TB; Kirsch, I; Klonizakis, M; Middlemass, J; Siriwardena, AN | 1 |
| Baier, PC | 1 |
| Crowe, SF; Stranks, EK | 1 |
| Albrecht, JS; Park, Y; Tom, SE; Wickwire, EM | 1 |
| Asaly, A; Kolenberg Geron, L; Matok, I; Perlman, A; Treves, N | 1 |
| Aschenbrenner, DS | 1 |
| Chan, V; Croteau, D; Harbourt, K; Nevo, ON; Zhang, R | 1 |
9 review(s) available for zaleplon and eszopiclone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sleep modulating agents.
Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents | 2019 |
Which medications are safe and effective for improving sleep at high altitude?
Topics: Acetamides; Acetazolamide; Altitude Sickness; Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazepines; Diphenhydramine; Eszopiclone; GABA Agonists; Humans; Hypnotics and Sedatives; Mountaineering; Piperazines; Pyridines; Pyrimidines; Sleep Initiation and Maintenance Disorders; Sleep Stages; Temazepam; Wakefulness; Zolpidem | 2008 |
Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.
Topics: Acetamides; Azabicyclo Compounds; Eszopiclone; Humans; Hypnotics and Sedatives; Indenes; Infections; Piperazines; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Risk; Zolpidem | 2009 |
Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.
Topics: Acetamides; Adult; Aged; Azabicyclo Compounds; Confidence Intervals; Eszopiclone; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Piperazines; Polysomnography; Pyridines; Pyrimidines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; United States; United States Food and Drug Administration; Zolpidem | 2012 |
The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.
Topics: Acetamides; Attention; Azabicyclo Compounds; Eszopiclone; Humans; Hypnotics and Sedatives; Memory; Piperazines; Psychomotor Performance; Pyridines; Pyrimidines; Zolpidem | 2014 |
Drugs for Insomnia.
Topics: Acetamides; Animals; Eszopiclone; Humans; Hypnotics and Sedatives; Plant Preparations; Pyridines; Pyrimidines; Sleep Initiation and Maintenance Disorders; Somnambulism; Zolpidem | 2015 |
Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis.
Topics: Accidental Falls; Acetamides; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Azabicyclo Compounds; Eszopiclone; Fractures, Bone; Humans; Middle Aged; Piperazines; Pyrimidines; Risk Assessment; Risk Factors; Sleep; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Zolpidem | 2018 |
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death.
Topics: Acetamides; Adult; Adverse Drug Reaction Reporting Systems; Aged; Drug Labeling; Eszopiclone; Female; Humans; Male; Middle Aged; Parasomnias; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Sleep; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Somnambulism; Time Factors; Treatment Outcome; Wounds and Injuries; Zolpidem | 2020 |
12 other study(ies) available for zaleplon and eszopiclone
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Greater incidence of depression with hypnotic use than with placebo.
Topics: Acetamides; Azabicyclo Compounds; Cross-Sectional Studies; Depressive Disorder, Major; Drug Prescriptions; Eszopiclone; Follow-Up Studies; Humans; Hypnotics and Sedatives; Incidence; Indenes; Long-Term Care; Odds Ratio; Piperazines; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; United States; United States Food and Drug Administration; Zolpidem | 2007 |
What every dentist should know about the "z-sedatives".
Topics: Acetamides; Azabicyclo Compounds; Drug Interactions; Eszopiclone; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Pyrimidines; Sleep Initiation and Maintenance Disorders; Zolpidem | 2007 |
Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep?
Topics: Acetamides; Animals; Azabicyclo Compounds; Carcinoma, Basal Cell; Eszopiclone; Humans; Indenes; Piperazines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Neoplasms; Sleep Initiation and Maintenance Disorders; United States; United States Food and Drug Administration | 2008 |
Possibility that certain hypnotics might cause cancer in skin.
Topics: Acetamides; Animals; Azabicyclo Compounds; Carcinoma, Basal Cell; Causality; Cross-Sectional Studies; Eszopiclone; Follow-Up Studies; Humans; Hypnotics and Sedatives; Incidence; Indenes; Melanoma; Piperazines; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Neoplasms; Sleep Initiation and Maintenance Disorders; United States; United States Food and Drug Administration; Zolpidem | 2008 |
Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder.
Topics: Acetamides; Adolescent; Adult; Azabicyclo Compounds; Bipolar Disorder; Eszopiclone; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Piperazines; Pyridines; Pyrimidines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Zolpidem | 2011 |
Sleep aid toxicosis in dogs: 317 cases (2004-2010).
Topics: Acetamides; Animals; Azabicyclo Compounds; Benzodiazepines; Comorbidity; Dog Diseases; Dogs; Eszopiclone; Female; Hypnotics and Sedatives; Male; Piperazines; Poison Control Centers; Prognosis; Pyridines; Pyrimidines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Zolpidem | 2011 |
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
Topics: Acetamides; Adult; Aged; Azabicyclo Compounds; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Eszopiclone; Half-Life; Hepatic Insufficiency; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Pyrimidines; Receptors, GABA-A; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam; United States; Zolpidem | 2012 |
[How well do Z-substances help in insomnia?].
Topics: Acetamides; Azabicyclo Compounds; Controlled Clinical Trials as Topic; Double-Blind Method; Eszopiclone; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Pyrimidines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Zolpidem | 2013 |
Nonbenzodiazepine Sedative Hypnotics and Risk of Fall-Related Injury.
Topics: Accidental Falls; Acetamides; Aged; Aged, 80 and over; Brain Injuries, Traumatic; Cross-Over Studies; Eszopiclone; Female; Hip Fractures; Hospitalization; Humans; Hypnotics and Sedatives; Male; Odds Ratio; Pyridines; Pyrimidines; Risk Assessment; Sleep Initiation and Maintenance Disorders; Zolpidem | 2016 |
Common Insomnia Drugs Receive Black Box Warning.
Topics: Acetamides; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Eszopiclone; Humans; Pyrimidines; Safety Management; Sleep Initiation and Maintenance Disorders; United States; United States Food and Drug Administration; Zolpidem | 2019 |